Long-Term Givinostat May Delay Motor Function Loss in DMD – Medscape
- Long-Term Givinostat May Delay Motor Function Loss in DMD Medscape
- EPIDYS Extension Studies Provide Context to Givinostat’s Longterm Efficacy and Safety Neurology live
- ITF announces updated long-term data for Duvyzat in DMD The Pharma Letter
- Data confirms Givinostat safety in Duchenne Muscular Dystrophy European Pharmaceutical Manufacturer
- ITF Therapeutics Announces Publication of Positive Long-Term Data Reinforcing Givinostat Efficacy and Safety as a Treatment for Duchenne Muscular Dystrophy Morningstar